Related Experiment Video
Updated: May 30, 2025

05:55
Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research
Published on: December 1, 2023
747
Update on autoimmune dementia and its precursors
1Department of Psychiatry and Psychotherapy, University Medical Center Göttingen, Von-Siebold-Str. 5, Göttingen 37075, Germany.
Behavioural Brain Research
|January 31, 2025
Summary
Autoimmune dementia involves novel neural antibodies impacting cognitive function. Understanding these autoantibodies and their mechanisms is crucial for developing targeted treatments and guidelines for this emerging disease.
Area of Science:
- Neurology
- Immunology
- Neuroscience
Background:
- Autoimmune dementia is an emerging neurological condition.
- Novel neural autoantibodies are increasingly linked to dementia and its precursors.
- The precise role of these autoantibodies in cognitive disorders requires further elucidation.
Purpose of the Study:
- To review known and emerging autoantibodies associated with cognitive disorders.
- To describe the pathogenic mechanisms of these antibodies.
- To discuss diagnostic and therapeutic approaches for autoimmune dementia.
Main Methods:
- Literature review of studies on neural autoantibodies and cognitive disorders.
- Analysis of pathogenic mechanisms including complement-dependent cytotoxicity and receptor antagonism.
- Discussion of established and novel autoantibodies in dementia and autoimmune encephalitis.
Main Results:
- Established antibodies like LGI1 and NMDAR antibodies are pathogenic.
- Mechanisms include complement-dependent cytotoxicity, receptor internalization, and synaptic alterations.
- Various autoantibodies are linked to neurodegenerative dementia and autoimmune encephalitis with dementia.
Conclusions:
- Autoimmune dementia is a heterogeneous entity with diverse autoantibody associations.
- Further research is needed to understand antibody significance and develop treatment guidelines.
- Immunotherapy response and testing methods warrant continued investigation.
Related Concept Videos
Autoimmune Disorders
379
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
379
Alzheimer's Disease: Overview
437
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
437
Dementia
92
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
92
Alzheimer's Disease: Treatment
158
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
158
Myasthenia Gravis: Overview and Treatment
1.1K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.1K
Parkinson's Disease: Overview
447
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
447

